Navigation Links
Boston Scientific Announces Results for Third Quarter Ended September 30, 2008
Date:10/21/2008

Litigation-related charges 334

Restructuring charges 20

Acquisition-related milestone (250)

Loss on assets held for sale 352

1,295 1,620

Operating income (loss) 28 (147)

Other income (expense):

Interest expense (112) (147)

Other, net 16 35

Loss before income taxes (68) (259)

Income tax (benefit) expense (6) 13

Net loss $(62) $(272)

Net loss per common share - basic $(0.04) $(0.18)

Net loss per common share - assuming

dilution $(0.04) $(0.18)

Weighted average shares outstanding -

basic 1,500.9 1,489.8

Weighted average shares outstanding -

assuming dilution 1,500.9 1,489.8

BOSTON SCIENTIFIC CORPORATION

NON-GAAP NET INCOME AND NET INCOME PER COMMON SHARE RECONCILIATIONS

(Unaudited)

Three Months Ended Three Months Ended

September 30, 2008 September 30, 2007

Impact per Impact per

In millions, except per Net (loss) diluted Net (loss) diluted

share data income share income share

GAAP results $(62) $(0.04) $(272) $(0.18)

Non-GAAP adjustments:

Acquisition-related (credits)

charges
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet
2. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
3. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
4. Boston Scientific Announces FDA Approval of TAXUS(R) Express2(TM) Atom(TM) Stent System, First Drug-Eluting Stent For Small Vessels
5. Boston Scientific to Participate in UBS Global Life Sciences Conference
6. Boston Scientific Announces Court Decision
7. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
8. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
9. NorthPoint Domain and Boston Medical Center Partner to Apply Advanced Patient Engagement Instruments to Pioneering Cardiac Robotic Surgery Program
10. TechCFO Adds Gary Strickland as Partner in Boston Office
11. Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Envera announced today that Michael McErlean has ... has an extensive background in cell production and served ... , Mike Matheny, President and Owner of ... join our team”. “Mike’s background is perfectly suited to ... and downstream processing equipment”, added Matheny. “Mike’s hands on ...
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013  Moderna ... revolutionary new treatment modality to enable the in ... John Reynders will join Moderna ... Reynders is a proven leader in ... phases of drug development, from discovery to translation, clinical ...
(Date:5/21/2013)... Lindsley F. Kimball Research Institute of the New York Blood ... Explorations winner, an initiative funded by the Bill ... , Head of the Laboratory of Molecular Parasitology will ... Innovative 3-D in vitro culturing system for ... to help eliminate onchocerciasis (river blindness) in Africa ...
(Date:5/21/2013)... a new study led by George Washington University ... nucleation of ice in small droplets is strongly ... at the nanoscale. The formation of ice at ... question whose answer also has important implications for ... crystallization of ice from supercooled water is generally ...
Breaking Biology Technology:Envera Appoints Michael McErlean Fermentation Manager 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2
... Strive to Measure ROI, Balance Business Benefits with ... Environmental Responsibility, FALLS ... supply chains are most constrained by the,inability to justify cost of ... conducted by CSC (NYSE: CSC ), Manhattan,Associates Inc. (Nasdaq: ...
... for Pandemic Planning -, NUTLEY, N.J., June 26 ... program that will allow U.S. businesses,to maintain access to ... situation, with limited upfront investment and more adaptability,to deal ... the new plan, businesses pay a nominal annual fee ...
... A study published in,the May issue of ... are,associated with improved listening comprehension and vocabulary ... Effect of Docosahexaenoic,Acid on Cognitive Functions in ... Study," evaluated whether DHA,supplementation had an effect ...
Cached Biology Technology:Study Reveals Greatest Barrier to Green Supply Chain Initiatives 2Study Reveals Greatest Barrier to Green Supply Chain Initiatives 3Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 2Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 3Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 4Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R) 5Results of Study in Pre-School Children Published in Clinical Pediatrics Adds to Support for Importance of Dietary DHA Intake 2Results of Study in Pre-School Children Published in Clinical Pediatrics Adds to Support for Importance of Dietary DHA Intake 3Results of Study in Pre-School Children Published in Clinical Pediatrics Adds to Support for Importance of Dietary DHA Intake 4
(Date:5/21/2013)... shows that the nation,s land and water resources could ... up to 25 billion gallons of algae-based fuel a ... yearly needs. , The findings come from an in-depth ... to grow significant amounts of algae in large, specially ... May 7 issue of Environmental Science and Technology ...
(Date:5/21/2013)... Mo. Cancers of all types become most deadly ... Once cancer has reached this stage, it becomes very ... tumors that can develop. Now, researchers at the University ... nanoparticles that target lymphoma tumor cells wherever they may ... of oncology in the MU College of Veterinary Medicine, ...
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2Fueling fitness on the final frontier 2
... from the University of Illinois at Champaign-Urbana have found ... a park in western Uganda are exchanging gastrointestinal bacteria ... of the E. coli strains migrating to chimps are ... , Their study will appear in the April 2007 ...
... A University of Florida-led study has determined that Titanis ... North America from South America long before a land ... MacFadden said his team used an established geochemical technique ... to revise the ages of terror bird fossils in ...
... for alternative energy, Florida Tech Professor of Biological ... from Aurora Biofuels for large-scale production of microalgae. ... in small-scale cultivation. , Lin will cultivate the ... Laboratory. His work is to test conditions that ...
Cached Biology News:E. coli bacteria migrating between humans, chimps in Ugandan park 2E. coli bacteria migrating between humans, chimps in Ugandan park 3'Terror bird' arrived in North America before land bridge, study finds 2
Mouse monoclonal antibody to PDK2 - pyruvate dehydrogenase kinase, isoenzyme 2...
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
... a direct antibiotic-based selection system for recombinant ... survival, eliminating the need for costly color ... close to 100% accuracy in recombinant selection. ... robot colony picking. This cloning kit ...
Biology Products: